185 related articles for article (PubMed ID: 32340500)
1. Efficacy and safety of ultrasonography-guided radiofrequency ablation for the treatment of T1bN0M0 papillary thyroid carcinoma: a retrospective study.
Xiao J; Zhang M; Zhang Y; Yan L; Lan Y; Zhu Y; Zhang Y; Lin L; Tang J; Luo Y
Int J Hyperthermia; 2020; 37(1):392-398. PubMed ID: 32340500
[No Abstract] [Full Text] [Related]
2. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study.
Xiao J; Zhang Y; Zhang M; Lan Y; Yan L; Luo Y; Tang J
Clin Endocrinol (Oxf); 2021 Apr; 94(4):684-691. PubMed ID: 33128786
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study.
Zhang M; Luo Y; Zhang Y; Tang J
Thyroid; 2016 Nov; 26(11):1581-1587. PubMed ID: 27445090
[TBL] [Abstract][Full Text] [Related]
5. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
Chung SR; Baek JH; Choi YJ; Lee JH
Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
[TBL] [Abstract][Full Text] [Related]
6. Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer After Radiofrequency Ablation: A Five-Year Retrospective Cohort Study.
Li X; Li Y; Yan L; Xiao J; Yang Z; Jing H; Zhang M; Luo Y
Thyroid; 2024 Jan; 34(1):54-63. PubMed ID: 37885207
[No Abstract] [Full Text] [Related]
7. Long-Term Outcomes and Risk Factors of Radiofrequency Ablation for T1N0M0 Papillary Thyroid Carcinoma.
Li X; Yan L; Xiao J; Li Y; Yang Z; Zhang M; Luo Y
JAMA Surg; 2024 Jan; 159(1):51-58. PubMed ID: 37878294
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up.
Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y
Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study.
Cao XJ; Liu J; Zhu YL; Qi L; Liu G; Wang HL; Wang ZH; Zhou Y; He JF; Guo JQ; Shi LL; Jian M; Shataer A; Yan GZ; Zhao ZL; Wei Y; Peng LL; Li Y; Che Y; Wang SR; Yu MA
J Clin Endocrinol Metab; 2021 Jan; 106(2):e573-e581. PubMed ID: 33107573
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-guided Radiofrequency Ablation for Cervical Lymph Nodes Metastasis from Papillary Thyroid Carcinoma.
Guang Y; Luo YK; Zhang Y; Zhang MB; Li N; Zhang Y; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):67-71. PubMed ID: 29532783
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer.
Lim HK; Baek JH; Lee JH; Kim WB; Kim TY; Shong YK; Hong SJ
Eur Radiol; 2015 Jan; 25(1):163-70. PubMed ID: 25199815
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients.
Yan L; Lan Y; Xiao J; Lin L; Jiang B; Luo Y
Eur Radiol; 2021 Feb; 31(2):685-694. PubMed ID: 32813103
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study.
Tong M; Wang L; Gai Z; Zhu Y; Che Y
Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
15. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
[No Abstract] [Full Text] [Related]
16. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma.
Ding M; Tang X; Cui D; Chi J; Shi Y; Wang T; Zhai B; Li P
Clin Radiol; 2019 Sep; 74(9):712-717. PubMed ID: 31253420
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of percutaneous ultrasound-guided thermal ablation in the treatment of cervical metastatic lymph nodes from papillary thyroid carcinoma.
Zhang S; Liu Y; Zhou B; Xu H
Clin Hemorheol Microcirc; 2024; 87(1):77-87. PubMed ID: 38250765
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.
Lin Y; Wu ZR; Shi YP; Ding M; Tang XY; He Y; Zhai B; Li P
J Clin Endocrinol Metab; 2023 Oct; 108(11):e1298-e1305. PubMed ID: 37220176
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a systematic review and meta-analysis.
Xue J; Teng D; Wang H
Int J Hyperthermia; 2022; 39(1):1300-1309. PubMed ID: 36195326
[TBL] [Abstract][Full Text] [Related]
20. US-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: Efficacy and Safety in a Large Population.
Lim HK; Cho SJ; Baek JH; Lee KD; Son CW; Son JM; Baek SM
Korean J Radiol; 2019 Dec; 20(12):1653-1661. PubMed ID: 31854153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
